Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/s0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Park JW, Chen M, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35(9):2155–2166. doi:10.1111/liv.12818
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3. doi:10.1053/j.gastro.2020.04.014
   PubMed Web of Science ®Google Scholar
• Zhang T, Merle P, Wang H, Zhao H, Kudo M. Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel? Hepatobiliary Surg Nutr. 2021;10(2):180–192. doi:10.21037/hbsn-2021-7
   PubMed Web of Science ®Google Scholar
• Zhou H, Song T. Conversion therapy and maintenance therapy for primary hepatocellular carcinoma. Biosci Trends. 2021;15(3):155–160. doi:10.5582/bst.2021.01091
   PubMed Web of Science ®Google Scholar
• Lau WY, Lai EC. Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability. Ann Surg Oncol. 2007;14(12):3301–3309. doi:10.1245/s10434-007-9549-7
   PubMed Web of Science ®Google Scholar
• Lewandowski RJ, Kulik LM, Riaz A, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant. 2009;9(8):1920–1928. doi:10.1111/j.1600-6143.2009.02695.x
   PubMed Web of Science ®Google Scholar
• Li QJ, He MK, Chen HW, et al. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: a Randomized Phase III Trial. J Clin Oncol. 2022;40(2):150–160. doi:10.1200/jco.21.00608
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang X, Mu H, et al. Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: a Retrospective Study. Front Oncol. 2021;11:729764. doi:10.3389/fonc.2021.729764
   PubMed Web of Science ®Google Scholar
• Deng ZC, Jiang WZ, Tang XD, Liu SH, Qin L, Qian HX. Laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 157 patients: a case controlled study with propensity score matching at two Chinese centres. Int J Surg. 2018;56:203–207. doi:10.1016/j.ijsu.2018.06.026
   PubMed Web of Science ®Google Scholar
• Sposito C, Battiston C, Facciorusso A, et al. Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma. Br J Surg. 2016;103(7):871–880. doi:10.1002/bjs.10137
   PubMed Web of Science ®Google Scholar
• Kabir T, Tan ZZ, Syn NL, et al. Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis. Br J Surg. 2021;109(1):21–29. doi:10.1093/bjs/znab376
   PubMed Web of Science ®Google Scholar
• Yoon YI, Kim KH, Kang SH, et al. Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: a Propensity Score Matched Analysis. Ann Surg. 2017;265(5):856–863. doi:10.1097/sla.0000000000002072
   PubMed Web of Science ®Google Scholar
• Cheung TT, Poon RT, Yuen WK, et al. Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg. 2013;257(3):506–511. doi:10.1097/SLA.0b013e31827b947a
   PubMed Web of Science ®Google Scholar
• Belli G, Limongelli P, Fantini C, et al. Laparoscopic and open treatment of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 2009;96(9):1041–1048. doi:10.1002/bjs.6680
   PubMed Web of Science ®Google Scholar
• Belli G, Fantini C, D’Agostino A, et al. Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results. Surg Endosc. 2007;21(11):2004–2011. doi:10.1007/s00464-007-9503-6
   PubMed Web of Science ®Google Scholar
• Sarpel U, Hefti MM, Wisnievsky JP, Roayaie S, Schwartz ME, Labow DM. Outcome for patients treated with laparoscopic versus open resection of hepatocellular carcinoma: case-matched analysis. Ann Surg Oncol. 2009;16(6):1572–1577. doi:10.1245/s10434-009-0414-8
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Fuks D, Kokudo N, Gayet B. Difficulty of Laparoscopic Liver Resection: proposal for a New Classification. Ann Surg. 2018;267(1):13–17. doi:10.1097/sla.0000000000002176
   PubMed Web of Science ®Google Scholar
• Zhu XD, Huang C, Shen YH, et al. Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma. Ann Surg Oncol. 2022. doi:10.1245/s10434-022-12530-z
   Web of Science ®Google Scholar
• Chong JU, Choi GH, Han DH, et al. Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Ann Surg Oncol. 2018;25(11):3308–3315. doi:10.1245/s10434-018-6653-9
   PubMed Web of Science ®Google Scholar
• Zhu XD, Huang C, Shen YH, et al. Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations. Liver Cancer. 2021;10(4):320–329. doi:10.1159/000514313
   PubMed Web of Science ®Google Scholar
• Hamaoka M, Kobayashi T, Kuroda S, et al. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: a retrospective cohort study. Int J Surg. 2017;44:223–228. doi:10.1016/j.ijsu.2017.06.082
   PubMed Web of Science ®Google Scholar
• He M, Li Q, Shi M. Potential Areas of Interest in a Trial of Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin for Hepatocellular Carcinoma-In Reply. JAMA Oncol. 2019;5(12):1806–1807. doi:10.1001/jamaoncol.2019.4058
   PubMed Web of Science ®Google Scholar
• Cheung TT, Dai WC, Tsang SH, et al. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: a Propensity Analysis at a Single Center. Ann Surg. 2016;264(4):612–620. doi:10.1097/sla.0000000000001848
   PubMed Web of Science ®Google Scholar
• Kim H, Suh KS, Lee KW, et al. Long-term outcome of laparoscopic versus open liver resection for hepatocellular carcinoma: a case-controlled study with propensity score matching. Surg Endosc. 2014;28(3):950–960. doi:10.1007/s00464-013-3254-3
   PubMed Web of Science ®Google Scholar
• Takahara T, Wakabayashi G, Beppu T, et al. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci. 2015;22(10):721–727. doi:10.1002/jhbp.276
   PubMed Web of Science ®Google Scholar
• Wang J, Zheng Z, Wu T, et al. Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: a Single-Center Real-World Study. J Hepatocell Carcinoma. 2022;9:999–1010. doi:10.2147/jhc.S379326
   PubMed Web of Science ®Google Scholar
• Brytska N, Han HS, Shehta A, Yoon YS, Cho JY, Choi Y. Laparoscopic liver resection for hepatitis B and C virus-related hepatocellular carcinoma in patients with Child B or C cirrhosis. Hepatobiliary Surg Nutr. 2015;4(6):373–378. doi:10.3978/j.issn.2304-3881.2015.04.06
   PubMed Web of Science ®Google Scholar
• Chen Z, Xie H, Hu M, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993–3036.
   PubMed Web of Science ®Google Scholar
• Frazee RC, Roberts JW, Okeson GC, et al. Open versus laparoscopic cholecystectomy. A comparison of postoperative pulmonary function. Ann Surg. 1991;213(6):651–653. doi:10.1097/00000658-199106000-00016
   PubMed Web of Science ®Google Scholar
• Scuderi V, Barkhatov L, Montalti R, et al. Outcome after laparoscopic and open resections of posterosuperior segments of the liver. Br J Surg. 2017;104(6):751–759. doi:10.1002/bjs.10489
   PubMed Web of Science ®Google Scholar
• Granito A, Bolondi L. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. Lancet Oncol. 2017;18(2):e101–e112. doi:10.1016/s1470-2045(16)30569-1
   PubMed Web of Science ®Google Scholar